METHODS: Urine samples were collected following-DRE from 15 institutions, and quantitation of KLK3, T2-ERG and PCA3 was performed on urine samples from over 1936 samples. In order to generate a model for prognostication, levels of PCA3 and T2-ERG were normalized to KLK3.
INTRODUCTION AND OBJECTIVES:
The four-kallikrein panel, commercially available as the 4Kscore, has been demonstrated to improve prediction of aggressive prostate cancer compared to prostate-specific antigen (PSA) alone or PSA in combination with free PSA. However, to date, the development and testing of the four-kallikrein panel has been limited primarily to studies conducted in White or African American men. Here we prospectively evaluated the four-kallikrein panel in a nested casecontrol study among African American (AA), Latino (LA), Japanese (JA), Native Hawaiian (NH) and White (WH) men in the Multiethnic Cohort (MEC).
METHODS: Pre-diagnostic blood levels of free, intact, total prostate specific antigen (PSA), human kallikrein-related peptidase 2 (hK2) and microseminoprotein-b (MSP) were measured among 2,227 incident prostate cancer cases and 2,189 controls. In statistical models we compared by AUC analysis the discriminative ability of the four-kallikrein panel to PSA for overall prostate cancer, GleasonGrade Group (GGG) 2 or higher, and aggressive disease (Gleason >7, non-localized disease, or death from prostate cancer) within and across all racial/ethnic groups.
RESULTS: The mean ages of the cases and controls at blood draw were 68 (range: 47-86) and 69 (47-87), respectively, and, for cases, the mean follow-up years was 4.8. For men with elevated PSA (!2.0 ng/ml; 1,669 cases and 664 controls), the AUC for GGG!2 cancer (n[1,077) was 0.78 (95% CI, 0.76-0.80) for the four-kallikrein panel compared to 0.75 (95% C.I. 0.72 -0.77) for free plus total PSA, and 0.68 (95% CI, 0.66-0.71) for total PSA alone. Discrimination was slightly enhanced for the four-kallikrein panel for aggressive disease (542 cases; 0.79 for panel vs. 0.75 for free plus total PSA vs. 0.68 for total PSA only). This improvement of the four-kallikrein over PSA was observed in each racial/ethnic group for overall prostate cancer ( 
PD64-10 IMPACT OF HEALTH LITERACY ON DECISION-MAKING FOR PROSTATE-SPECIFIC ANTIGEN SCREENING IN THE UNITED STATES
David-Dan Nguyen*, Quoc-Dien Trinh, Paul L. Nguyen, Boston, MA; Jesse D. Sammon, Portland, ME INTRODUCTION AND OBJECTIVES: Multiple factors, such as widespread reporting of guidelines, influence a patient's decision to undergo prostate-specific antigen (PSA) testing. Following the USPSTF recommendations,patients with improved health literacy (HL) would presumably have a lower probability of screening (given increased awareness of guidelines). We sought to identify the impact of HL on informed decision-making (IDM) and PSA screening decisions.
METHODS: Using the 2016 Behavioral Risk Factor Surveillance System (BRFSS) dataset, we examined data from 13 states that administered the optional "Health Literacy" module. Men aged 50 and older were examined. Complex samples multivariable logistic regression models were computed to the odds of receiving PSA screening. Age, race, education level, marital status, health insurance,health status, residence location, annual income, recommendation by a healthcare provider (HCP) and health literacy category were included as covariates. The interactions between health literacy and HCP Recommendation were examined.
RESULTS: We identified 12.249M men with a rate of PSA screening of 33.4%. Among this cohort, only 34.5% self-identified as having optimal health literacy. Rates of PSA screening were highest amongst the most health literate (42.2% vs 23.3%). While the receipt of Healthcare Provider Recommendation to undergo PSA screening was the most important independent predictor (OR [10.357, CI [9.103, 11 .784]) of screening. This effect was significantly diminished in the population of men with the highest health literacy (p-int <0.05).
CONCLUSIONS: In the uncertain environment of multiple contradictory screening guidelines, men who report higher levels of health literacy had higher levels of screening. While recommendation from a healthcare provider to undergo PSA screening remains the most important predictor, the effect is significantly moderated by HL. These findings highlight the dynamic interplay between providers and their patients that should inform the creation and promulgation of guidelines.
